Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol PVD-202: A Phase 2, Randomized, Double-Masked, Placebo-Controlled Multicenter Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD in Non-Proliferative Diabetic Retinopathy

NCT02435862 is registered in ClinicalTrials.gov with Allegro Ophthalmics, LLC as lead sponsor.

NCT NCT02435862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02435862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol PVD-202: A Phase 2, Randomized, Double-Masked, Placebo-Controlled Multicenter Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD in Non-Proliferative Diabetic Retinopathy
Lead sponsor
Allegro Ophthalmics, LLC
Phase
Phase 2
Overall status
Completed
Start date
February 1, 2015
Completion date
August 10, 2017
Enrollment
105 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

non-proliferative diabetic retinopathy